ReviewInternational journal of nanomedicine2025
Nanomaterials for the Treatment of Contamination by Nosocomial Pathogens in Intensive Care Units.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Materials of care: Engineering the future of the ICU.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Healthcare systems worldwide face a significant challenge from nosocomial infections. These infections are associated with increased rates of disease, mortality, and healthcare expenses. Common issues with traditional treatment approaches include antibiotic resistance and inadequate pathogen targeting. Utilizing nanoparticles for the targeted administration of antimicrobial medications to infection areas has proven to enhance treatment outcomes while maintaining biocompatibility. Traditional diagnostic methods still rely on microbiological culture and susceptibility testing, while molecular technologies are seeing increased usage for rapid diagnosis. This review mainly aims to draw attention to the present state of nosocomial infections by outlining their prevalence and the ways in which nanotechnology is used to treat these illnesses. This study provides a thorough examination of the nanotherapeutic methods that have recently developed, with an emphasis on the clinical implications of different types of nanoparticles for the purpose of reducing the prevalence of nosocomial infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.